Center for Scientific Review; Amended Notice of Meeting, 4668 [2018-02034]

Download as PDF 4668 Federal Register / Vol. 83, No. 22 / Thursday, February 1, 2018 / Notices The meeting will be held on February 7, 2018 at 6:00 p.m. and end February 8, 2018 9:00 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: January 29, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–02031 Filed 1–31–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Nanotechnology Study Section, February 8, 2018, 8:00 a.m. to February 9, 2018, 5:00 p.m., Baltimore Marriott Waterfront, 700 Aliceanna Street, Baltimore, MD 21202 which was published in the Federal Register on January 5, 2018, V–83 Pg. 683. The meeting will be held on February 7, 2018 at 7:00 p.m. and end February 9, 2018 at 5:00. The meeting location remains the same. The meeting is closed to the public. Dated: January 29, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–02034 Filed 1–31–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration sradovich on DSK3GMQ082PROD with NOTICES Advisory Committee for Women’s Services (ACWS); Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of a meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Advisory Committee for Women’s Services (ACWS) on February 14, 2018. The meeting will include discussions on assessing SAMHSA’s current strategies related to women experiencing homelessness with behavioral health needs, and SAMHSA’s strategies related to women in the criminal justice system with behavioral health needs. Additionally, the ACWS will be speaking with the Assistant Secretary of Mental Health and Substance Use regarding priorities VerDate Sep<11>2014 19:34 Jan 31, 2018 Jkt 244001 and directions around behavioral health services and access for women and children. The meeting is open to the public and will be held at SAMHSA, 5600 Fishers Lane, Rockville, MD, 20857, in Conference Room 5E29. Attendance by the public will be limited to space available. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions should be forwarded to the contact person (below) by February 5, 2018. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations are encouraged to notify the contact person on or before February 5, 2018. Five minutes will be allotted for each presentation. The meeting may be accesed via telephone. To attend on site, obtain the call-in number and access code, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register on-line at https://nac.samhsa.gov/ Registration/meetingsRegistration.aspx, or communicate with SAMHSA’s Designated Federal Officer, Ms. Valerie Kolick (see contact information below). Substantive meeting information and a roster of ACWS members may be obtained either by accessing the SAMHSA Committees’ Web https:// www.samhsa.gov/about-us/advisorycouncils/meetings, or by contacting Ms. Kolick. Committee Name: Substance Abuse and Mental Health Services Administration Advisory Committee for Women’s Services (ACWS). Date/Time/Type: Wednesday, February 14, 2018, from: 9:00 a.m. to 4:45 p.m. EDT, Open. Place: SAMHSA, 5600 Fishers Lane, Conference Room 5E29, Rockville, Maryland 20857. Contact: Valerie Kolick, Designated Federal Official, SAMHSA’s Advisory Committee for Women’s Services, 5600 Fishers Lane, Rockville, MD 20857, Telephone: (240) 276–1738, Email: Valerie.kolick@samhsa.hhs.gov. Carlos Castillo, Committee Management Officer, Substance Abuse and Mental Health, Services Administration. [FR Doc. 2018–02010 Filed 1–31–18; 8:45 am] BILLING CODE 4162–20–P PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. AGENCY: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHScertified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at https://www.samhsa.gov/ workplace. FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240–276–2600 (voice). SUPPLEMENTARY INFORMATION: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); April 30, 2010 (75 FR 22809); and on January 23, 2017 (82 FR 7920) The Mandatory Guidelines were initially developed in accordance with SUMMARY: E:\FR\FM\01FEN1.SGM 01FEN1

Agencies

[Federal Register Volume 83, Number 22 (Thursday, February 1, 2018)]
[Notices]
[Page 4668]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02034]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the 
Nanotechnology Study Section, February 8, 2018, 8:00 a.m. to February 
9, 2018, 5:00 p.m., Baltimore Marriott Waterfront, 700 Aliceanna 
Street, Baltimore, MD 21202 which was published in the Federal Register 
on January 5, 2018, V-83 Pg. 683.
    The meeting will be held on February 7, 2018 at 7:00 p.m. and end 
February 9, 2018 at 5:00. The meeting location remains the same. The 
meeting is closed to the public.

    Dated: January 29, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-02034 Filed 1-31-18; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.